相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。National General Health Screening Program in Korea: history, current status, and future direction A scoping review
Dong Wook Shin et al.
PRECISION AND FUTURE MEDICINE (2022)
Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case-control study
Junghee Ha et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
Daniel K. Burns et al.
LANCET NEUROLOGY (2021)
Defective Mitochondrial Pyruvate Flux Affects Cell Bioenergetics in Alzheimer's Disease-Related Models
Alice Rossi et al.
CELL REPORTS (2020)
Atrial Fibrillation Increases the Risk of Early-Onset Dementia in the General Population: Data from a Population-Based Cohort
Dongmin Kim et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Pioglitazone Therapy in Patients With Stroke and Prediabetes A Post Hoc Analysis of the IRIS Randomized Clinical Trial
J. David Spence et al.
JAMA NEUROLOGY (2019)
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Lisa Vermunt et al.
ALZHEIMERS & DEMENTIA (2019)
Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus
Hannah Seok et al.
SCIENTIFIC REPORTS (2019)
Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone
Lawrence H. Young et al.
CIRCULATION (2018)
Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke)
Shadi Yaghi et al.
CIRCULATION (2018)
Stroke and dementia risk: A systematic review and meta-analysis
Elzbieta Kuzma et al.
ALZHEIMERS & DEMENTIA (2018)
The low dose (7.5 mg/day) pioglitazone is beneficial to the improvement in metabolic parameters without weight gain and an increase of risk for heart failure
Hiroki Adachi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Effects of pioglitazone on the incidence of dementia in patients with diabetes
Ping-Song Chou et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry
Juraj Secnik et al.
DIABETES CARE (2017)
Tripchlorolide Attenuates β-amyloid Generation via Suppressing PPARγ-Regulated BACE1 Activity in N2a/APP695 Cells
Nan Lin et al.
MOLECULAR NEUROBIOLOGY (2016)
Effect of pioglitazone medication on the incidence of dementia
Michael T. Heneka et al.
ANNALS OF NEUROLOGY (2015)
Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review
Natalie McCormick et al.
PLOS ONE (2015)
Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
Mark Yarchoan et al.
DIABETES (2014)
Challenges of Guarantee-Time Bias
Anita Giobbie-Hurder et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
Julio Rosenstock et al.
DIABETES CARE (2012)
Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease
James L. Searcy et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Upregulation of hepatic LRP1 by rosiglitazone: a possible novel mechanism of the beneficial effect of thiazolidinediones on atherogenic dyslipidemia
Jae Hoon Moon et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
David S. Geldmacher et al.
ARCHIVES OF NEUROLOGY (2011)
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
Kawser Akter et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Landmark Analysis at the 25-Year Landmark Point
Urania Dafni
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Tomohiko Sato et al.
NEUROBIOLOGY OF AGING (2011)
Pioglitazone: side effect and safety profile
Priya Shah et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia
Yoshikane Izawa et al.
BRAIN RESEARCH (2009)
Multi-state models for the analysis of time-to-event data
Luis Meira-Machado et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2009)
Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon 4
Fumiko Irie et al.
ARCHIVES OF NEUROLOGY (2008)
Pioglitazone Inhibits the Expression of Inflammatory Cytokines From Both Monocytes and Lymphocytes in Patients With Impaired Glucose Tolerance
Wei-Yang Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
M. Amine Bouhlel et al.
CELL METABOLISM (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hematoma resolution as a target for intracerebral hemorrhage treatment:: Role for peroxisome proliferator-activated receptor γ in microglia/macrophages
Xiurong Zhao et al.
ANNALS OF NEUROLOGY (2007)
Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes
H Sourij et al.
DIABETES CARE (2006)
Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes
DJ Betteridge et al.
DIABETOLOGIA (2005)
Peroxisome proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide
IE Camacho et al.
JOURNAL OF NEUROSCIENCE (2004)
A mitochondrial cascade hypthesis for sporadic Alzheimer's disease
RH Swerdlow et al.
MEDICAL HYPOTHESES (2004)
Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity
AD Dobrian et al.
HYPERTENSION (2004)
Peroxisome proliferator-activated receptor γ thiazolidinedione agonists increase glucose metabolism in astrocytes
C Dello Russo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Regulation of β-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor α
CK Combs et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort
JA Luchsinger et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
分享论文
